Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 21, 2007 - Issue 14
96
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

A myxobacterium strain Sorangium cellulosum AHB125 producing epothilone B and other anticancer substances

, , , , , , & show all
Pages 1256-1265 | Received 21 May 2007, Accepted 14 Sep 2007, Published online: 12 Dec 2007
 

Abstract

A myxobacterium strain AHB125 belonging to genus Sorangium cellulosum was isolated from Anhui area in China and identified with morphological analysis by electron microscopy and phase contrast microscope according to Bergey's manual of systematic bacteriology (8th Ed.). Its high-antitumor bioactivity metabolites was evaluated by bioassay-directed screening technique with B16 tumor cell line etc. Research results showed that it exhibited not only strong antitumor ability bioactivities and broad-spectrum antitumor abilities to B16, Bel7402, H446, SGC7901 cell lines, but also has selectivity and pertinence to B16 and SGC7901 cell lines. The compound was confirmed as epothilone B by HPLC and LC/MS analysis, compared to the epothilone B standard sample. Bioassay indicated that there were other high-bioactive substances in the metabolites.

Acknowledgements

We sincerely like to thank Prof. Y.H. Ma and Ms Y. Zeng (Institute of Microbiology, Chinese Academy of Science, Beijing) for identification of the bacteria.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.